全文获取类型
收费全文 | 12950篇 |
免费 | 980篇 |
国内免费 | 30篇 |
专业分类
耳鼻咽喉 | 123篇 |
儿科学 | 499篇 |
妇产科学 | 372篇 |
基础医学 | 1973篇 |
口腔科学 | 353篇 |
临床医学 | 1598篇 |
内科学 | 2530篇 |
皮肤病学 | 367篇 |
神经病学 | 1237篇 |
特种医学 | 328篇 |
外科学 | 1024篇 |
综合类 | 105篇 |
一般理论 | 4篇 |
预防医学 | 1194篇 |
眼科学 | 197篇 |
药学 | 829篇 |
中国医学 | 15篇 |
肿瘤学 | 1212篇 |
出版年
2023年 | 95篇 |
2022年 | 57篇 |
2021年 | 260篇 |
2020年 | 278篇 |
2019年 | 331篇 |
2018年 | 322篇 |
2017年 | 285篇 |
2016年 | 340篇 |
2015年 | 433篇 |
2014年 | 523篇 |
2013年 | 718篇 |
2012年 | 1068篇 |
2011年 | 1055篇 |
2010年 | 631篇 |
2009年 | 542篇 |
2008年 | 873篇 |
2007年 | 918篇 |
2006年 | 879篇 |
2005年 | 841篇 |
2004年 | 806篇 |
2003年 | 729篇 |
2002年 | 655篇 |
2001年 | 116篇 |
2000年 | 70篇 |
1999年 | 96篇 |
1998年 | 129篇 |
1997年 | 106篇 |
1996年 | 73篇 |
1995年 | 77篇 |
1994年 | 68篇 |
1993年 | 63篇 |
1992年 | 40篇 |
1991年 | 44篇 |
1990年 | 26篇 |
1989年 | 28篇 |
1988年 | 29篇 |
1987年 | 25篇 |
1986年 | 13篇 |
1985年 | 19篇 |
1984年 | 25篇 |
1983年 | 27篇 |
1982年 | 22篇 |
1981年 | 22篇 |
1980年 | 18篇 |
1978年 | 14篇 |
1977年 | 26篇 |
1975年 | 13篇 |
1974年 | 13篇 |
1967年 | 14篇 |
1965年 | 14篇 |
排序方式: 共有10000条查询结果,搜索用时 265 毫秒
1.
Tellapragada Chaitanya Ydsten Karin Andersson Ternhag Anders Giske Christian G. 《European journal of clinical microbiology & infectious diseases》2022,41(7):1093-1098
European Journal of Clinical Microbiology & Infectious Diseases - We investigated the concordance between the Unyvero Hospitalized Pneumonia (HPN) application and quantitative culture for... 相似文献
2.
Hendrik Kröning Thomas Göhler Thomas Decker Marc Grundeis Georgi Kojouharoff Jörg Lipke Dieter Semsek Enno Moorahrend Annette Sauer Harald-Robert Bruch Rüdiger Liersch Arnd Nusch Ursula Vehling-Kaiser Manfred Welslau Ralf Grunewald Hanns-Detlev Harich Marcel Stephany Jens Uhlig Rebecca de Buhr Melanie Frank Cathrin Hogrefe Norbert Marschner Karin Potthoff Frank Hartmann Timo Reisländer Ingo Schwaner 《International journal of cancer. Journal international du cancer》2023,153(6):1227-1240
The prospective, multicenter, noninterventional TACTIC study assessed effectiveness and safety of trifluridine/tipiracil (FTD/TPI) in patients with metastatic colorectal cancer (mCRC) in a real-world setting in Germany, thus evaluating the external validity of the findings from the pivotal RECOURSE trial. Primary endpoint was overall survival (OS). Secondary objectives included progression-free survival (PFS), safety, and quality of life (QoL). Subgroups comprised patients with good (<3 metastatic sites at inclusion, ≥18 months from diagnosis of first metastasis to inclusion) or poor (remaining patients) prognostic characteristics (GPC/PPC). GPC without liver metastases was considered best prognostic characteristics (BPC). In total, 307 eligible patients (pretreated or not suitable for other available therapies) were treated with FTD/TPI. Overall, median [95%-CI] OS was 7.4 months [6.4-8.6], median PFS was 2.9 months [2.8-3.3]. In BPC (n = 65) and GPC (n = 176) compared to PPC (n = 124) subgroup, median OS (13.3 [9.1-17.6] vs 8.9 [7.6-9.8] vs 5.1 [4.4-7.0] months) and median PFS (4.0 [3.3-5.3] vs 3.4 [3.0-3.7] vs 2.6 [2.4-2.8] months) were longer. Patient-reported QoL, assessed by validated questionnaires (EQ-5D-5L, PRO-CTCAE), was stable throughout FTD/TPI treatment. Predominant FTD/TPI-related adverse events of grades 3 or 4 were neutropenia (13.0%), leukopenia (7.5%), and anemia (5.2%). Altogether, palliative FTD/TPI therapy in patients with pretreated mCRC was associated with prolonged survival, delayed progression, maintained health-related QoL, and manageable toxicity. Low metastatic burden and indolent disease were favorable prognostic factors for survival. TACTIC confirms the effectiveness and safety of FTD/TPI, highlighting its value in routine clinical practice. 相似文献
3.
Philip J. Lupo Ruth E. Luna-Gierke Tiffany M. Chambers Björn Tavelin Michael E. Scheurer Beatrice Melin Karin Papworth 《International journal of cancer. Journal international du cancer》2020,146(3):791-802
Perinatal factors have been associated with soft tissue sarcomas (STS) in case-control studies. However, (i) the contributions of factors including fetal growth remain unknown, ( ii ) these factors have not been examined in cohort studies and (iii) few assessments have evaluated risk in specific STS subtypes. We sought to identify the role of perinatal and familial factors on the risk of STS in a large population-based birth cohort. We identified 4,023,436 individuals in the Swedish Birth Registry born during 1973–2012. Subjects were linked to the Swedish Cancer Registry, where incident STS cases were identified. We evaluated perinatal and familial factors obtained from Statistics Sweden, including fetal growth, gestational age, and presence of a congenital malformation. Poisson regression was used to estimate incidence rate ratios (IRRs) and 95% confidence intervals (CIs) for associations between perinatal factors and STS overall, as well as by common subtypes. There were 673 individuals diagnosed with STS in 77.5 million person-years of follow-up. Having a congenital malformation was associated with STS (IRR = 1.70, 95% CI: 1.23–2.35). This association was stronger (IRR = 2.90, 95% CI: 1.25–6.71) in recent years (2000–2012). Low fetal growth was also associated with STS during the same time period (IRR = 1.86, 95% CI: 1.05–3.29). Being born preterm was associated with rhabdomyosarcoma (IRR = 1.74, 95% CI: 1.08–2.79). In our cohort study, those with congenital malformations and other adverse birth outcomes were more likely to develop a STS compared to their unaffected contemporaries. These associations may point to disrupted developmental pathways and genetic factors influencing the risk of STS. 相似文献
4.
Laila Sara Arroyo Mühr Camilla Lagheden Jiayao Lei Carina Eklund Sara Nordqvist Kleppe Pr Sparn Karin Sundstrm Joakim Dillner 《British journal of cancer》2020,123(12):1790
Background Human papillomavirus (HPV) is a necessary cause of cervical cancer, although some invasive cervical cancers may test negative by HPV PCR. We previously requested all invasive cervical cancers in Sweden during 10 years and subjected them to PCR. We also optimised methods for deep sequencing of formalin-fixed paraffin-embedded samples.Methods Using Novaseq 6000, we simultaneously sequenced total DNA and cDNA from 392 HPV PCR-negative cervical cancers. Non-human reads were queried against all known HPVs. The complete database now contains PCR and/or deep sequencing data on 2850 invasive cervical cancers.Results HPV sequences were detected in 169/392 of HPV PCR-negative cervical cancers. Overall, 30 different HPV types were detected, but only 5 types were present in proportions above 3% of cancers. More than 92% of tumours were HPV-positive in PCR and/or sequencing (95% confidence interval: 91.1–93.1%). Exploring possible reasons for failure to previously detect HPV suggest that more sensitive type-specific PCRs for HPV 31, 33, 45 and 73 targeting retained regions of HPV would have detected most of these (117/392).Conclusions Unbiased deep sequencing provides comprehensive data on HPV types in cervical cancers and appears to be an important tool for quality assurance of HPV screening.Subject terms: Infectious-disease diagnostics, Viral infection, Cervical cancer 相似文献
5.
6.
Joshua P. Entrop Caroline E. Weibull Karin E. Smedby Lasse H. Jakobsen Andreas K. Øvlisen Daniel Molin Ingrid Glimelius Anna Marklund Harald Holte Alexander Fosså Knut B. Smeland Tarec C. El-Galaly Sandra Eloranta 《International journal of cancer. Journal international du cancer》2023,153(4):723-731
Childbirth rates in classical Hodgkin lymphoma (cHL) survivors have historically been reduced compared to the general population. Understanding if contemporary treatment protocols are associated with reduced fertility is crucial as treatment guidelines shift toward more liberal use of intensive chemotherapy. We identified 2834 individuals aged 18-40 years with cHL in Swedish and Danish lymphoma registers, and in the clinical database at Oslo University Hospital diagnosed 1995-2018, who were linked to national medical birth registers. Cox regression adjusted for stage, performance status, year, and age at diagnosis was used to estimate hazard ratios (HRs) and 95% confidence intervals (CI) contrasting time to first childbirth by treatment groups (ABVD, 2-4 BEACOPP, 6-8 BEACOPP) up to 10 years after diagnosis. Overall, 74.8% of patients were treated with ABVD, 3.1% with 2-4 BEACOPP and 11.2% with 6-8 BEACOPP. Adjusted HRs comparing childbirth rates in individuals treated with 6-8 BEACOPP, and 2-4 BEACOPP to ABVD were 0.53 (CI: 0.36-0.77) and 0.33 (CI: 0.12-0.91) for males, and 0.91 (CI: 0.61-1.34) and 0.38 (CI: 0.12-1.21) for females. Cumulative incidence of childbirths after 10 years was 19.8% (CI: 14.5%-27.0%) for males and 34.3% (CI: 25.8%-45.6%) for females treated with 6-8 BEACOPP. Proportions of children born after assisted reproductive technique (ART) treatments were 77.4% (CI: 60.2-88.6%) for males following 6-8 BEACOPP, and <11% for females. Among ABVD treated patients the corresponding proportions were 12.2% (CI: 8.5%-17.3%) and 10.6% (CI: 7.4%-14.9%). BEACOPP treatment is associated with decreased childbirth rates compared to ABVD in male, but not female, cHL patients, despite widespread access to ART in the Nordics. 相似文献
7.
8.
Jølving Line Riis Erb Karin Nørgård Bente Mertz Fedder Jens Larsen Michael Due 《European journal of epidemiology》2021,36(4):445-452
European Journal of Epidemiology - The Danish National Register of assisted reproductive technology (ART) was initially established in 1994. The register comprises complete information on all ART... 相似文献
9.
10.